跳至主要内容
临床试验/EUCTR2005-003903-35-GB
EUCTR2005-003903-35-GB进行中(未招募)1 期

: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis

ewcastle-upon-Tyne Hospitals NHS Trust0 个研究点目标入组 20 人开始时间: 2005年12月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. McDonald criteria for diagnosis of MS (McDonald, 2001)16
  • 2. Clinical evidence of Cerebellar Tremor.
  • 3. Aged 18-60
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. There is evidence of a further significant MS relapse during the trial
  • 2. Evidence of resting tremor, or Holmes (rubral) tremor
  • 3. Patients already on specific anti-tremor medication
  • 4. Pregnant or breast feeding mothers

研究者

发起方
ewcastle-upon-Tyne Hospitals NHS Trust

相似试验